- Home
- Dermatology
- Long-Term Safety and Efficacy of Anifrolumab in SLE: Insights from the Phase III LTE Study
1mo3 min read
Medical Article
Introduction: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem involvement and a fluctuating course of disease activity (1). It affects organs such as the skin, kidneys, joints, and central nervous system, and is associated with significant morbidity and mortality (1). Patients often require long-term

Long-Term Safety and Efficacy of Anifrolumab in SLE: Insights from the Phase III LTE Study
1197 Reached3 Comments
Similar Content

Acute Renal Failure in Child Due to High Dose of Indomethacin
685 Reached6 Comments

Rubella Syndrome in Neonate
1401 Reached12 Comments9 Likes

Black Lesion in Old Female
1974 Reached5 Comments11 Likes

Chronic Hyperplastic Candidiasis Of The Oral Mucosa
858 Reached9 Comments11 Likes

Autopsy Findings of Deceased Renal Transplant Recipient
594 Reached8 Comments5 Likes
